Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation
The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Abstract
Research over the years has shown that causes of Alzheimer's disease are not well understood, but over the past years, the involvement of epigenetic mechanisms in the developing memory formation either under pathological or physiological conditions has become clear. The term epigenetics represents the heredity of changes in phenotype that are independent of altered DNA sequences. Different studies validated that cytosine methylation of genomic DNA decreases with age in different tissues of mammals, and therefore, the role of epigenetic factors in developing neurological disorders in aging has been under focus. In this review, we summarized and reviewed the involvement of different epigenetic mechanisms especially the DNA methylation in Alzheimer's disease (AD), late-onset Alzheimer's disease (LOAD), familial Alzheimer's disease (FAD), and autosomal dominant Alzheimer's disease (ADAD). Down to the minutest of details, we tried to discuss the methylation patterns like mitochondrial DNA methylation and ribosomal DNA (rDNA) methylation. Additionally, we mentioned some therapeutic approaches related to epigenetics, which could provide a potential cure for AD. Moreover, we reviewed some recent studies that validate DNA methylation as a potential biomarker and its role in AD. We hope that this review will provide new insights into the understanding of AD pathogenesis from the epigenetic perspective especially from the perspective of DNA methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“abnormal DNA methylation patterns have been reported in several genes associated with AD [227,228,229].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [227]
In the citing paper
“differences in overall methylation have been observed in AD-affected brain regions”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [227]
Citations
Cites
1 retracted
Kuhn, D. E., Nuovo, G. J., Terry, A. V., Martin, M. M., Malana, G. E., Sansom, S. E., Pleister, A. P., Beck, W. D., Head, E., Feldman, D. S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033407 · Cited by 117
RetractedCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
DNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“Studies on mice have shown that during gametogenesis and early development, this event occurs frequently in order to remethylate the demethylated repetitive sequences during those stages of embryogenesis [18].”
BackgroundConversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836 · cited 1×
“In neurons, DNA hydroxymethylation can occur in result of oxidative stress or the action ten-eleven-translocation-1(TET1), which is a specific oxidative enzyme [21, 22].”
BackgroundDelivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Genome-wide methylation profiles reveal quantitative views of human aging rates
Hannum, G., Guinney, J., Zhao, L., Zhang, L., Hughes, G., Sadda, S., Klotzle, B., Bibikova, M., Fan, J.-B., Gao, Y., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.016 · Cited by 4,270
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039 · cited 1×
“A decreased and silenced transcription of genes is achieved when MBDP along with other epigenetic components forms inactive and compact heterochromatin [20].”
Background
Research works printed but not linked: 1
- van Emburgh BO, Robertson KD (2008) DNA methyltransferases and methyl-CpG binding proteins as multifunctional regulators of chromatin structure and development in mammalian cells. In: Tost J (ed) Epigenetics. Caister Academic Press, Norfolk, pp. 22–61
Cited by
Clinical epigenetics: seizing opportunities for translation
Berdasco, M., & Esteller, M. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0074-2 · Cited by 498
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115522 · Cited by 329
Ribosome biogenesis in disease: new players and therapeutic targets
Jiao, L., Liu, Y., Yu, X.-Y., Pan, X., Zhang, Y., Tu, J., Song, Y.-H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01285-4 · Cited by 313
Cellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
“It has been demonstrated that in AD brains changes in DNA methylation affect to a few common gene loci which play an essential role in the formation of Aβ plaques (Lord and Cruchaga, 2014; Watson et al., 2016; Qazi et al., 2018; Armstrong et al., 2019; Esposito and Sherr, 2019; Prasad and Jho, 2019).”
BackgroundDNA methylation and regulation of gene expression: Guardian of our health
Dhar, G. A., Saha, S., Mitra, P., & Nag Chaudhuri, R. (2021) · The Nucleus · doi:10.1007/s13237-021-00367-y · Cited by 242
Methyltransferases: Functions and Applications
Abdelraheem, E., Thair, B., Varela, R. F., Jockmann, E., Popadić, D., Hailes, H. C., Ward, J. M., Iribarren, A. M., Lewkowicz, E. S., Andexer, J. N., et al. (2022) · ChemBioChem · doi:10.1002/cbic.202200212 · Cited by 198
The basis of cellular and regional vulnerability in Alzheimer’s disease
Mrdjen, D., Fox, E. J., Bukhari, S. A., Montine, K. S., Bendall, S. C., & Montine, T. J. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02054-4 · Cited by 160
Bhatti, G. K., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00369 · Cited by 145
Zhang, L., Silva, T. C., Young, J. I., Gomez, L., Schmidt, M. A., Hamilton-Nelson, K. L., Kunkle, B. W., Chen, X., Martin, E. R., & Wang, L. (2020) · Nature Communications · doi:10.1038/s41467-020-19791-w · Cited by 139
Shireby, G., Dempster, E. L., Policicchio, S., Smith, R. G., Pishva, E., Chioza, B., Davies, J. P., Burrage, J., Lunnon, K., Seiler Vellame, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33394-7 · Cited by 125
Redefining the IBDs using genome-scale molecular phenotyping
Furey, T. S., Sethupathy, P., & Sheikh, S. Z. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0118-x · Cited by 129
Toader, C., Tătaru, C. P., Munteanu, O., Șerban, M., Covache-Busuioc, R.-A., Ciurea, A. V., & Enyedi, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312613 · Cited by 124
Diversity of the reaction mechanisms of SAM-dependent enzymes
Sun, Q., Huang, M., & Wei, Y. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.011 · Cited by 114
Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer’s Disease
Stoccoro, A., Siciliano, G., Migliore, L., & Coppedè, F. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170139 · Cited by 110
“DNA methylation changes at both gene-specific and global levels have been detected in AD [3].”
Vasanthakumar, A., Davis, J. W., Idler, K., Waring, J. F., Asque, E., Riley-Gillis, B., Grosskurth, S., Srivastava, G., Kim, S., Nho, K., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00864-y · Cited by 98
Rasmi, Y., Shokati, A., Hassan, A., Aziz, S. G., Bastani, S., Jalali, L., Moradi, F., & Alipour, S. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.12.002 · Cited by 96
“Aβ accumulation (Qazi et al., 2018) Progressive dementia”
DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses
Dan, H., Zhang, S., Zhou, Y., & Guan, Q. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s217767 · Cited by 86
“Low levels of DNA methylation are associated with the activation of proto-oncogenes, which leads to genomic instability, while high levels of DNA methylation silence the promoters of tumour suppressor genes, which results in the inactivation of tumour suppressor genes.(21,22) Studies have shown that the proportion of…”
BackgroundEpigenetics of chronic inflammatory diseases
Stylianou, E. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s129027 · Cited by 79
“important roles in brain functionality and memory as well as in physiological aging.(84) The epigenetics field in AD has transitioned from reductionist, candidate gene approaches to genome-wide profiling of disease-associated epigenetic changes.”
BackgroundInfluentialPrecision Medicine and Public Health: New Challenges for Effective and Sustainable Health
Traversi, D., Pulliero, A., Izzotti, A., Franchitti, E., Iacoviello, L., Gianfagna, F., Gialluisi, A., Izzi, B., Agodi, A., Barchitta, M., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020135 · Cited by 88
“Epigenetics is known to play a role in both neurodegenerative and neuropsychiatric diseases, as DNA methylation changes have been described in Alzheimer’s disease [52], Parkinson’s disease [53], amyotrophic lateral sclerosis [54], schizophrenia [55], major depressive disorder [56], and post-traumatic stress disorder […”
BackgroundSenescence: A DNA damage response and its role in aging and Neurodegenerative Diseases
Shreeya, T., Ansari, M. S., Kumar, P., Saifi, M., Shati, A. A., Alfaifi, M. Y., & Elbehairi, S. E. I. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1292053 · Cited by 84
“According to several lines of evidence, defects in autophagy and lysosomal dysfunction may have a role in the etiology and development of neurodegenerative illnesses, including AD (Qazi et al., 2018; Nixon, 2013).”
BackgroundNanomedicine and epigenome. Possible health risks
Smolková, B., Dušinská, M., & Gábelová, A. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.07.020 · Cited by 77
Lee, C., Chang, C., Lin, C., Lai, H., Kao, Y.-H., Cheng, S., Chen, H., Liao, Y., Faivre, É., Buée, L., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1030-z · Cited by 66
The epigenetic modification of DNA methylation in neurological diseases
Li, L., Chen, R., Zhang, H., Li, J., Huang, H., Weng, J., Tan, H., Guo, T., Wang, M., & Xie, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401962 · Cited by 67
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Guo, J., Cheng, J., North, B. J., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.001 · Cited by 55
The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
Cellai, L., Carvalho, K., Faivre, É., Deleau, A., Vieau, D., Buée, L., Blum, D., Mériaux, C., & Gómez‐Murcia, V. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00520 · Cited by 58
“…contribution of adenosine pathways to blood-brain-barrier permeability (Kim and Bynoe, 2015), physiological plasticity, neurotrophin actions (Rebola et al., 2008; Jerónimo-Santos et al., 2014) or even to the peripheral adaptive immune system lastly recognized as playing an important role in…”
BackgroundSmall molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration
Jiang, D., Li, T., Guo, C., Tang, T.-S., & Liu, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00953-4 · Cited by 54
Neurodegenerative disorders: Assessing the impact of natural vs drug‐induced treatment options
Mathur, S., Gawas, C. G., Ahmad, I. Z., Wani, M., & Tabassum, H. (2023) · Aging Medicine · doi:10.1002/agm2.12243 · Cited by 56
Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease
Xiao, X., Liu, X., & Jiao, B. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.538301 · Cited by 55
Roles and Mechanisms of DNA Methylation in Vascular Aging and Related Diseases
Xu, H., Li, S., & Liu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.699374 · Cited by 57
Pyka, P., Garbo, S., Fioravanti, R., Jacob, C., Hittinger, M., Handzlik, J., Zwergel, C., & Battistelli, C. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104062 · Cited by 50
Systems healthcare: a holistic paradigm for tomorrow
Fiandaca, M. S., Mapstone, M. E., Connors, E. E., Jacobson, M., Monuki, E. S., Malik, S., Macciardi, F. M., & Federoff, H. J. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0521-2 · Cited by 54
“and the genome, through epigenetic modifications [71, 72], and especially DNA methylation [73, 74].”
BackgroundDNA methylation in the pathology of Alzheimer's disease: from gene to cognition
Poon, C. H., Tse, L. S. R., & Lim, L. W. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14373 · Cited by 51
Li, X., Wu, Z., Si, X., Li, J., Wu, G., & Wang, M. (2025) · European journal of medical research · doi:10.1186/s40001-025-02699-w · Cited by 54
Hu, S., Tao, J., Peng, M., Ye, Z., Chen, Z., Chen, H., Yu, H., Wang, B., Fan, J., & Ni, B. (2023) · Biomarker Research · doi:10.1186/s40364-023-00486-5 · Cited by 41
“Aberrations in DNA methylation are found at the genomic level in most tumors, including lung cancer, as well as in patients with non-neoplastic diseases such as Alzheimer’s disease and heart failure [13, 14].”
BackgroundNew Insights into the Molecular Bases of Familial Alzheimer’s Disease
D’Argenio, V., & Sarnataro, D. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020026 · Cited by 44
Pathak, G. A., Silzer, T. K., Sun, J., Zhou, Z., Daniel, A. A., Johnson, L. A., O’Bryant, S. E., Phillips, N., & Barber, R. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190634 · Cited by 40
“Methylation at CpG (cytosine-phosphate-guanine) sites throughout the genome is known to affect down-stream expression of various genes and has been implicated in normal aging and disease processes [11, 12].”
Neurodegenerative movement disorders: An epigenetics perspective and promise for the future
Murthy, M. N., Cheng, Y. Y., Holton, J. L., & Bettencourt, C. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12757 · Cited by 45
“, [50, 51]); therefore in the following section, we will focus on”
BackgroundChen, L., Xu, S., Shen, Q., Yu, H., Pei, S., Zhang, Y., He, X., Wang, Q., & Li, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215217 · Cited by 39
The Way to a Human’s Brain Goes Through Their Stomach: Dietary Factors in Major Depressive Disorder
Aly, J. S., & Engmann, O. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.582853 · Cited by 39
Kloske, C. M., Dugan, A. J., Weekman, E. M., Winder, Z., Patel, E., Nelson, P. T., Fardo, D. W., & Wilcock, D. M. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab085 · Cited by 38
Hernández, H. G., Sandoval-Hernández, A. G., Garrido‐Gil, P., Labandeira-García, J. L., Zelaya, M. V., Bayón, G. F., Fernández, A. F., Fraga, M. F., Arboleda, G., & Arboleda, H. (2018) · Epigenomics · doi:10.2217/epi-2017-0160 · Cited by 39
Utility of DNA Methylation as a Biomarker in Aging and Alzheimer’s Disease
Milicic, L., Porter, T., Vacher, M. A., & Laws, S. M. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220109 · Cited by 40
“Epigenetic modifications are heritable phenotypic changes that do not alter the DNA sequence [12].”
BackgroundHypermethylation of TRIM59 and KLF14 Influences Cell Death Signaling in Familial Alzheimer’s Disease
Wężyk, M., Spólnicka, M., Pośpiech, E., Pepłońska, B., Zbieć-Piekarska, R., Ilkowski, J., Styczyńska, M., Barczak, A. K., Zboch, M., Filipek-Gliszczyńska, A., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6918797 · Cited by 37
Mass spectrometry imaging technology in metabolomics: A systematic review
Gao, S., Zhao, J., Guan, Y., Tang, Y., Li, Y., & Liu, L. (2022) · Biomedical Chromatography · doi:10.1002/bmc.5494 · Cited by 39
New RNA-Based Breakthroughs in Alzheimer’s Disease Diagnosis and Therapeutics
Riscado, M., Baptista, B., & de Sousa, F. P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091397 · Cited by 35
Diabetes and dementia: Clinical perspective, innovation, knowledge gaps
Savelieff, M. G., Chen, K. S., Elzinga, S. E., & Feldman, E. L. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108333 · Cited by 35
Hart, D. A., & Zernicke, R. F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00156 · Cited by 53
Chromatin regulation in complex brain disorders
Bastle, R. M., & Maze, I. S. (2019) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.07.004 · Cited by 31
Oxidative Stress in Alzheimer’s Disease: The Shortcomings of Antioxidant Therapies
Pappolla, M. A., Martins, R. N., Poeggeler, B., Omar, R. A., & Perry, G. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240659 · Cited by 29
“5) Epigenetic Changes: Epigenetic modifications in AD could arise from environmental influences that might predispose individuals to the disease [184].”
Aschner, M., Skalny, A. V., Santamaría, A., da Rocha, J. B. T., Mansouri, B., Tizabi, Y., Madeddu, R., Lu, R., Lee, E.-S., & Tinkov, A. A. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04214-9 · Cited by 30
“Correspondingly, altered methylation of genes regulating tau phosphorylation, amyloid beta formation [48], as well as BDNF, and sorbin and SH3 domain containing 3 (SORBS3) [49] were shown to contribute to AD pathogenesis.”
Shao, W., Xiang, S., Zhang, Z., Huang, K., & Zhang, J. (2020) · Methods · doi:10.1016/j.ymeth.2020.04.008 · Cited by 33
Preventive electroacupuncture reduces cognitive deficits in a rat model of D-galactose-induced aging
Yu, C.-C., He, C., Du, Y.-J., Gao, S., Lin, Y.-F., Wang, S.-Q., Wang, S., Wang, J., Wang, X., Jiang, T., et al. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.297090 · Cited by 27
“Accumulating evidence indicates that abnormal DNA methylation could contribute to the pathogenesis of AD and lead to cognitive dysfunction (Qazi et al., 2018).”
BackgroundThe impact of epigenetic mechanisms in migraine: Current knowledge and future directions
Gallardo, V. J., Vila‐Pueyo, M., & Pozo‐Rosich, P. (2023) · Cephalalgia · doi:10.1177/03331024221145916 · Cited by 29
“Indeed, epigenetic abnormalities have been frequently found in neurological disorders, including epilepsy (64), Parkinson disease (65), Alzheimer disease (66), and amyotrophic lateral sclerosis (67); in neuropathic pain (68), and in psychiatric disorders, such as major depressive disorder (69); although many potential…”
BackgroundAlzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 30
Epigenetic mechanisms in amyotrophic lateral sclerosis: A short review
Dolinar, A., Ravnik‐Glavač, M., & Glavač, D. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.03.005 · Cited by 28
Liu, T., Du, D., Zhao, R., Xie, Q., & Dong, Z. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127440 · Cited by 25
Ulaganathan, S., & Pitchaimani, A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121918 · Cited by 25
Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
Onyango, I. G., Bennett, J. P., & Stokin, G. B. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211208125855 · Cited by 22
Luz, D. A., Pinheiro, A. M., Fontes-Júnior, E. A., & Maia, C. D. S. F. (2023) · Medicinal Research Reviews · doi:10.1002/med.21957 · Cited by 23
“All these modifications have been related to aging and correlated disorders, including neurodegenerative diseases.(52,53) Repression of genes related to cell death, plasticity, and induction of proinflammatory/apoptotic genes have been linked to cognitive disorders, eliciting a promissory target to future treatments.”
BackgroundExploring the potential of probiotics in Alzheimer's disease and gut dysbiosis
Sowmiya, S., Ls, D., Rajendran, P., Harikrishnan, N., & Ankul Singh, S. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.11.004 · Cited by 25
“Methylation of cytosine residues on a particular DNA molecule ’ s C-5 atom is the most well-studied instance of epigenetics in the process of gene silencing (Qazi et al., 2018).”
Efficacy of Digital Dance on Brain Imagery, Cognition, and Health: Randomized Controlled Trial
Tung, H., Kuo, C.-Y., Lee, P., Chang, C.-W., Chou, K., Lin, C., & Chen, L. (2024) · Journal of Medical Internet Research · doi:10.2196/57694 · Cited by 22
Mercorio, R., Pergoli, L., Galimberti, D., Favero, C., Carugno, M., Valle, E. D., Barretta, F., Cortini, F., Scarpini, E. A., Valentina, V. B., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180242 · Cited by 23
“A growing number of studies showed an epigenetic contribution in AD [25].”
Bayazid, A. B., & Lim, B. O. (2024) · Nutrients · doi:10.3390/nu16111554 · Cited by 22
Kawakami, S., Yamato, R., Kitamura, K., Watanabe, Y., Kabasawa, K., Takahashi, A., Saito, T., Kobayashi, R., Oshiki, R., Takachi, R., et al. (2023) · Maturitas · doi:10.1016/j.maturitas.2023.107788 · Cited by 19
An Epigenetic Manifestation of Alzheimer's Disease: DNA Methylation
Feng, B., Zheng, J., Cai, Y., Han, Y., Han, Y., Wu, J., Feng, J., & Zheng, K. (2024) · Actas Españolas de Psiquiatría · doi:10.62641/aep.v52i3.1595 · Cited by 19
“First, it plays a pivotal role in maintaining genomic stability and integrity [6].”
BackgroundPersonalized Management and Treatment of Alzheimer’s Disease
Cacabelos, R., Naidoo, V., Martínez-Iglesias, O. A., Corzo, L., Cacabelos, N., Pego, R., & Carril, J. C. (2022) · Life · doi:10.3390/life12030460 · Cited by 25
Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development
Cacabelos, R., Naidoo, V., Martínez-Iglesias, O. A., Corzo, L., Cacabelos, N., Pego, R., & Carril, J. C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2573-6_13 · Cited by 19
Jain, S., Bhushan, B., Mishra, A. K., & Singh, R. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106413 · Cited by 20
Himalian, R., Singh, S. K., & Singh, M. P. (2021) · Journal of the American Nutrition Association · doi:10.1080/07315724.2021.1904305 · Cited by 21
DNA methylation: The epigenetic mechanism of Alzheimer's disease
Qin, H., Liu, J., Fang, C., Deng, Y., & Zhang, Y. (2023) · Ibrain · doi:10.1002/ibra.12121 · Cited by 16
“10 These studies have shown that there is a relationship between DNA methylation and the pathogenesis of AD.”
BackgroundLiang, R. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1370-7_10 · Cited by 16
RNA‐Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins
Rabbani, S. A., El‐Tanani, M., Sharma, S., El‐Tanani, Y., Kumar, R., Saini, M., Yadav, M., Khan, M. A., & Parvez, S. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70110 · Cited by 16
“Additional studies have reported reduced PSEN1 and PSEN2 expression following treatment with RNAi methods, including siRNA and shRNA (Qazi et al. 2018).”
Han, P., Liu, Q., & Xiang, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.11163 · Cited by 16
“DNA methylation abnormalities have been found at the genome level in the majority of tumors, including lung cancer (20,21), and the frequency of CpG island hypermethylation in tumor cells is much higher compared with that of gene mutation (22).”
BackgroundWei, X., Du, P., & Zhao, Z. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136196 · Cited by 15
Systems biology of Alzheimer’s Disease: a scoping review of key pathways and mechanisms
Bice, P. J., Nho, K. T., Ertekin‐Taner, N., & Saykin, A. J. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00934-4 · Cited by 18
“Epigenetic modifications are initiated and sustained by DNA methylation, histone modification and non-coding RNA gene silencing [306].”
Urdánoz‐Casado, A., de Gordoa, J. S., Robles, M., Roldán, M., Zelaya, M. V., Blanco‐Luquin, I., & Mendióroz, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147682 · Cited by 15
“To date, the most widely studied epigenetic mechanisms are DNA methylation and post-transcriptional histone modifications [23,24].”
BackgroundThe Future of Epigenetics: Emerging Technologies and Clinical Applications
Iyer, K. A., Tenchov, R., Sasso, J. M., Thite, T., Deng, Y., & Zhou, Q. A. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00729 · Cited by 15
The effects of environmental stressors on candidate aging associated genes
Andrawus, M., Sharvit, L. E., Shekhidem, H. A., Roichman, A., Cohen, H. Y., & Atzmon, G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110952 · Cited by 14
Wang, F., Xu, C., Chen, W., Duan, S., Xu, S., Dai, J., & Wang, Q. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210540 · Cited by 13
“The pathogenesis of AD is closely related to epige-netics, and DNA modifications such as methylation can provide more evidence for the etiology of AD. large number of studies have shown that epigenetic changes in AD risk genes may become potential biomarkers for AD [7, 29].”
Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer’s Disease
He, C., Huang, Z., Yu, C.-C., Wang, H., Zhou, H., & Kong, L.-H. (2020) · Current Medical Science · doi:10.1007/s11596-020-2283-0 · Cited by 11
Mechanisms underlying LncRNA SNHG1 regulation of Alzheimer’s disease involve DNA methylation
Chen, H., Zhang, C.-J., Zhao, Z.-Y., Gao, Y., Zhao, J.-T., Li, X., Zhang, M., & Wang, H. (2024) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2024.2334248 · Cited by 10
“Several investigators noted that the epigenetic mechanisms of DNA methylation were associated with AD (Gao et al. 2022; Qazi et al. 2018).”
BackgroundChen, F., Wang, N., & He, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.884367 · Cited by 11
“DNA methylation, as one of the epigenetically important mechanisms, has been demonstrated to have a place in AD pathogenesis (Mohn et al., 2008; Qazi et al., 2018; Sharma et al., 2020), and genes and proteins associated with DNA methylation are potential biomarkers in AD (Qazi et al., 2018).”
BackgroundHu, J., Yang, Y. X., Lv, X., Lao, Z., & Yu, L. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.116828 · Cited by 10
regionalpcs improve discovery of DNA methylation associations with complex traits
Eulalio, T. Y., Sun, M., Gevaert, O., Greicius, M. D., Montine, T. J., Nachun, D. C., & Montgomery, S. B. (2025) · Nature Communications · doi:10.1038/s41467-024-55698-6 · Cited by 9
“AD, a neurodegenerative disorder affecting approximately 50 million people globally, is marked by progressive memory loss and cognitive decline 42 – 44 .”
Wang, X., Liu, L., Jiang, X., Saredy, J., Xi, H., Cueto, R., Sigler, D., Khan, M., Wu, S., Ji, Y. H., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01311-9 · Cited by 9
“Altered DNA and histone methylation have been suggested as a mechanism underlying AD development and neuropathology [33].”
BackgroundWang, F., Liang, Y., & Wang, Q. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01646-x · Cited by 9
“As a neurodegenerative disease, the pathogenesis of AD is also closely related to methylation [4].”
Han, F., Liu, S., Jing, J., Li, H., Yuan, Y., & Sun, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s246995 · Cited by 9
Detecting Brain Structure-Specific Methylation Signatures and Rules for Alzheimer’s Disease
Li, Z., Guo, W., Zeng, T., Yin, J., Feng, K., Huang, T., & Cai, Y. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.895181 · Cited by 9
Ramirez, P., Sun, W., Dehkordi, S. K., Zare, H., Pascarella, G., Carninci, P., Fongang, B., Bieniek, K. F., & Frost, B. E. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70852 · Cited by 9
The Role of BMI1 in Late-Onset Sporadic Alzheimer’s Disease
Hogan, R., Flamier, A., Nardini, E., & Bernier, G. (2020) · Genes · doi:10.3390/genes11070825 · Cited by 9
Tiwari, P., Dwivedi, R., Kaushik, M., Tripathi, M., & Dada, R. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02363-2 · Cited by 10
“Epigenome-wide association studies (EWAS) and hydroxymethylation analyses have provided compelling evidence for the presence of differentially methylated regions (DMRs) and differentially hydroxymethylated regions (DhMRs) in AD brains compared to age-matched controls (Qazi et al. 2018).”
Zhao, Y. M., Zhang, Y., Meng, S., Chen, B., Dong, X., Guo, X., Guo, F., Zhang, R., Cui, H., & Li, S. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221076 · Cited by 8
“[35], DNA/RNA methylation plays a vital role in neurodegenerative processes.”
BackgroundLi, W., Rang, Y., Liu, H., & Liu, C. (2023) · Phytotherapy Research · doi:10.1002/ptr.7908 · Cited by 8
Methylated Ccfdna from Plasma Biomarkers of Alzheimer’s Disease Using Targeted Bisulfite Sequencing
Guemri, J., Pierre‐Jean, M., Brohard, S., Oussada, N., Horgues, C., Bonnet, É., Mauger, F., & Deleuze, J. (2022) · Epigenomics · doi:10.2217/epi-2021-0491 · Cited by 8
González-Molina, L. A., Dekker, A. D., Deyn, P. P. D., Dolga, A. M., & Rots, M. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18516-8.00014-4 · Cited by 8
The effect of GNAQ methylation on GnRH secretion in sheep hypothalamic neurons
Zhai, M., Zhao, Z., Yang, M., Liang, Y., Liang, H., Xie, Y., & Han, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29021 · Cited by 7
“DNA methylation is a kind of modification that does not change the original base sequence of DNA.(16,23) Folate can provide methyl groups for DNA methylation, directly participating in the process of DNA methylation and inhibiting gene expression.”
BackgroundThree-dimensional cell culture technologies in the study of Alzheimer’s disease: a narrative review
Chacón, P. E. A., Irineo‐Moreno, V., & Loera‐Valencia, R. (2025) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-24-00016 · Cited by 8
Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort
Daniel, A. A., Silzer, T. K., Sun, J., Zhou, Z., Hall, C. L., Phillips, N., & Barber, R. C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221031 · Cited by 7
“Epigenetic factors regulate gene function through chemical modification of DNA (most often via methylation) that does not alter the sequence [20].”
BackgroundDNA Methylation in Aging and Alzheimer's Disease
Cheng, R., Shu, J., Chen, H., Li, M., Cheng, X., & Liu, L. (2024) · Human Brain · doi:10.37819/hb.3.2027 · Cited by 5
“The methylation status of CpG islands, often located in gene promoter regions, is a critical determinant of gene expression [10].”
Metadata
- Authors
- Qazi, T. J., Quan, Z., Mir, A., & Qing, H.
- Affiliations
- Beijing Institute of Technology (CN)
- International Islamic University, Islamabad (PK)
- Corresponding author
- Qing, Hong
- Venue
- Molecular Neurobiology
- Published
- 2017-01-14
- Volume
- 55
- Issue
- 2
- Pages
- 1026-1044
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2572342044
- Cited by
- 153
- References
- 195
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 22 · 2023: 23 · 2022: 15 · 2021: 18 · 2020: 20 · 2019: 8 · 2018: 12 · 2017: 9
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81671268)
- Ministry of Science and Technology of the People’s Republic of China (No. 2013YQ03059514)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, DNA methylation, epigenetics, late-onset Alzheimer's disease, familial Alzheimer's disease, autosomal dominant Alzheimer's disease, mitochondrial DNA methylation, aging, memory formation, epigenetic biomarkers, epigenetic therapy, Alzheimer's disease pathogenesis
- MeSH terms
- Alzheimer Disease, DNA, Mitochondrial, Humans, Mitochondria, DNA Methylation, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.